Bengaluru-based Stelis Biopharma, the biotech arm of Strides Pharma Science, has raised USD 195 million by means of Series B and Series C funding, which the corporate will use to repay debt and for common company functions.
Welcome! Log into your account
Recover your password
A password will be e-mailed to you.